Implement Strategies to Tackle the IVIG Shortage

Dwindling supplies will lead to questions about how to handle the intravenous immune globulin (IVIG) shortage.

The shortage seems to be due to demand that is outpacing plasma long manufacturing times.

Expect your hospital to reserve IVIG for severe acute cases, such as Guillain-Barre, Kawasaki disease, or myasthenia gravis crisis. You may also see IVIG alternatives when possible...such as plasmapheresis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote